HOT NEWS
Bayer
The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Secondary Prevention after an Acute Coronary Syndrome 2167
2 Results of ROCKET AF Study of Bayer’s Xarelto® (Rivaroxaban) 4229
3 Bayer continues positive momentum 3979
4 Bayer advances research in the area of pulmonary hypertension 4794
5 VEGF Trap-Eye Submitted for EU Marketing Authorization 5335
6 Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes 5669
7 Bayer off to a successful start to 2011 4903
8 Bayer affirms the positive benefit-risk profile of its drospirenone- containing oral contraceptives 5526
9 Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 5382
10 OncoTrack: A new International consortium launches project in the area of genomic cancer diagnostics 6131
11 Bayer and Onyx Initiate Phase III Trial of Nexavar® in Combination with Chemotherapy 6544
12 Organizational changes at Bayer HealthCare 4346
13 Bayer Initiates Phase III Trial of Regorafenib in Metastatic or Unresectable Gastrointestinal Stromal Tumors 6671
14 New oral contraceptive regimen submitted for marketing authorization in the EU 3898
15 Bayer's Contour USB simplifies diabetes management in everyday life 4389
16 Bayer lifts sales and earnings again 3991
17 Significant Survival Advantage with Betaferon Treatment 5107
18 Bayer's Xarelto® Recognised with 2010 International Prix Galien Award 4017
19 Bayer Diabetes Care simplifies life with diabetes 4025
20 LEVITRA 10mg Orodispersible Tablet for the Treatment of Erectile Dysfunction approved in Europe 6568
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3
Bookmark and Share